Can a simple breath test catch flu in High-HIV regions?

NCT ID NCT07030075

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study in Lusaka, Zambia, aims to measure how common influenza, RSV, and COVID-19 are among adults with flu-like symptoms, comparing those with and without HIV. Researchers will follow participants for two weeks to track symptom progression and outcomes. They will also test whether a breath-based sampling method can accurately detect these viruses compared to standard nasal swabs, and ask participants about their experience with each method.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Exhaled breath aerosol sampling (a non-invasive diagnostic method)
What this could lead to
If successful, this could improve flu diagnosis in high-HIV settings and support faster, more acceptable testing for respiratory infections.
What could go wrong
This is an observational study, so it won't test a treatment. The breath sampling method may not be as accurate as standard swabs, and results may not apply beyond this specific population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chawama 1st level Hospital

    RECRUITING

    Lusaka, Lusaka Province, 10101, Zambia

  • Kanyama 1st Level Hospital

    RECRUITING

    Lusaka, Lusaka Province, 10101, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.